Regeneron Announces Presentation at 25th Annual JPMorgan Healthcare Conference
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Jan. 9, 2007--(Nasdaq: REGN) will webcast its presentation at the 25th Annual JPMorgan Healthcare Conference in San Francisco, CA on January 11, 2007.
Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, will provide an overview of the Company and its clinical programs. The presentation is scheduled to be broadcast live on Thursday, January 11 at 8:00 a.m. Pacific Time. The session may be accessed through the Company's website (www.regeneron.com on the Events page, under the Investor Relations heading) at the time of the presentation. An archived version of the presentation will be available after the live webcast through February 10, 2007.
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.
Additional information about Regeneron and recent news releases are available on Regeneron's worldwide web site at www.regeneron.com
CONTACT: Regeneron Pharmaceuticals, Inc.
Charles Poole, Vice President, Investor Relations
914-345-7640
charles.poole@regeneron.com
or
Lauren Tortorete, Media Relations
212-845-5609
ltortorete@biosector2.com
SOURCE: Regeneron Pharmaceuticals, Inc.